Cite
MiR-22 may Suppress Fibrogenesis by Targeting TGFβR I in Cardiac Fibroblasts.
MLA
Hong, Yuan, et al. “MiR-22 May Suppress Fibrogenesis by Targeting TGFβR I in Cardiac Fibroblasts.” Cellular Physiology & Biochemistry (Karger AG), vol. 40, no. 6, Dec. 2016, pp. 1345–53. EBSCOhost, https://doi.org/10.1159/000453187.
APA
Hong, Y., Cao, H., Wang, Q., Ye, J., Sui, L., Feng, J., Cai, X., Song, H., Zhang, X., & Chen, X. (2016). MiR-22 may Suppress Fibrogenesis by Targeting TGFβR I in Cardiac Fibroblasts. Cellular Physiology & Biochemistry (Karger AG), 40(6), 1345–1353. https://doi.org/10.1159/000453187
Chicago
Hong, Yuan, Huaming Cao, Qiang Wang, Jianlin Ye, Lijun Sui, Jinhua Feng, Xiaojun Cai, Huizhu Song, Xiuhong Zhang, and Xichuang Chen. 2016. “MiR-22 May Suppress Fibrogenesis by Targeting TGFβR I in Cardiac Fibroblasts.” Cellular Physiology & Biochemistry (Karger AG) 40 (6): 1345–53. doi:10.1159/000453187.